Gabriela Alexe

23PUBLICATIONS
178CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursInnate immunityMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 14, 2026
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|May 05, 2026
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

|Mar 19, 2026
Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation.

Emily A Cmarik, Abhishek Wahi, Sayali S Chandekar

|Jan 08, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemia.

Fanny Gonzales, Constanze Schneider, Gabriela Alexe

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

Pageof 4

Frequent Collaborators

15 joint publications

Kimberly Stegmaier

9 joint publications

Yana Pikman

5 joint publications

Allen Thayakumar

4 joint publications

Lina Benajiba